Neonatal levels of acute phase proteins and later risk of non-affective psychosis
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, there have been very few longitudinal studies of inflammatory markers and either psychosis25 or depression, and the inconsistent results may be the result of methodologic differences.26-28”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Genome-wide association study identifies five new schizophrenia loci
The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) · Nature Genetics · doi:10.1038/ng.940 · Cited by 1,919
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775 · cited 1×
“BDNF and tPA are both required for long-term potentiation, considered to be the molecular mechanism underlying learning and memory.(57) Interestingly, low circulating levels of BDNF are observed in patients with schizophrenia and non-affective psychoses, with the most notable deficit in first-episode, drug-naive patie…”
BackgroundMeta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742 · cited 2×
“For example, patients are reported to have an increased incidence of autoimmune diseases, exhibit altered levels of multiple inflammatory mediators (reviewed by Miller et al.(13)) and have glial cell activation.”
BackgroundCommon variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677
Deverman, B. E., & Patterson, P. H. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.002 · Cited by 865
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030516 · Cited by 582
Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs
The Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ), Lee, S. H., The International Schizophrenia Consortium (ISC), The Molecular Genetics of Schizophrenia Collaboration (MGS), DeCandia, T. R., Ripke, S., Yang, J., Sullivan, P. F., Goddard, M. E., Keller, M. C., et al. (2012) · Nature Genetics · doi:10.1038/ng.1108 · Cited by 579
Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers
Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C.-Y., Agerbo, E., & Mortensen, P. B. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.521 · Cited by 527
Reiner, A. P., Wurfel, M. M., Lange, L. A., Carlson, C. S., Nord, A. S., Carty, C. L., Rieder, M. J., Desmarais, C., Jenny, N. S., Iribarren, C., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.167437 · Cited by 85
Erythrocyte ferritin in human neonates: maternofetal iron kinetics revisited
TCHERNIA, G., ARCHAMBEAUD, M. P., YVART, J., & DIALLO, D. (1996) · Clinical & Laboratory Haematology · doi:10.1046/j.1365-2257.1996.00170.x · Cited by 20
Research works printed but not linked: 60
- Mortensen PB, Pedersen MG, Pedersen CB . Psychiatric family history and schizophrenia risk in Denmark: which mental disorders are relevant? Psychol Med 2010; 40: 201–210. · DOI · Paper page
- Torrey EF, Bartko JJ, Yolken RH . Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 2012; 38: 642–647. · DOI · Paper page
- Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O et al. Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med 1999; 340: 603–608. · DOI · Paper page
- Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–752. · DOI · Paper page
- Jia P, Wang L, Fanous AH, Chen X, Kendler KS, Zhao Z . A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. J Med Genet 2012; 49: 96–103. · DOI · Paper page
- Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753–757. · DOI · Paper page
- Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry, advance online publication, 22 May 2012; doi:10.1038/mp.2012.67. · DOI · Paper page
- Chen SJ, Chao YL, Chen CY, Chang CM, Wu EC, Wu CS et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry 2012; 200: 374–380. · DOI · Paper page
- van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 2008; 64: 820–822. · DOI · Paper page
- Brown AS, Cohen P, Greenwald S, Susser E . Nonaffective psychosis after prenatal exposure to rubella. Am J Psychiatry 2000; 157: 438–443. · DOI · Paper page
- Buka SL, Cannon TD, Torrey EF, Yolken RH . Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 2008; 63: 809–815. · DOI · Paper page
- Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007; 61: 688–693. · DOI · Paper page
- Karlsson H, Blomstrom A, Wicks S, Yang S, Yolken RH, Dalman C . Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am J Psychiatry 2012; 169: 625–632. · DOI
- Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004; 161: 889–895. · DOI · Paper page
- Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH . Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001; 15: 411–420. · DOI · Paper page
- Meyer U, Feldon J . Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 2010; 90: 285–326. · DOI · Paper page
- Hsiao EY, Patterson PH . Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011; 25: 604–615. · DOI · Paper page
- Gabay C, Kushner I . Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–454. · DOI · Paper page
- Bauer J, Lengyel G, Thung SN, Jonas U, Gerok W, Acs G . Human fetal hepatocytes respond to inflammatory mediators and excrete bile. Hepatology 1991; 13: 1131–1141. · DOI
- de Villiers WJ, Louw JP, Strachan AF, Etsebeth SM, Shephard EG, de Beer FC . C-reactive protein and serum amyloid A protein in pregnancy and labour. Br J Obstet Gynaecol 1990; 97: 725–730. · DOI
- Cannon M, Jones PB, Murray RM . Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 2002; 159: 1080–1092. · DOI · Paper page
- Fawzi MH, Fawzi MM, Fawzi MM, Said NS . C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia. Psychiat Res 2011; 190: 91–97. · DOI
- Fan X, Pristach C, Liu EY, Freudenreich O, Henderson DC, Goff DC . Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiat Res 2007; 149: 267–271. · DOI · Paper page
- Meyer JM, McEvoy JP, Davis VG, Goff DC, Nasrallah HA, Davis SM et al. Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Biol Psychiatry 2009; 66: 1013–1022. · DOI · Paper page
- Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R . C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res 2007; 93: 261–265. · DOI · Paper page
- Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R . Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr Res 2012; 134: 83–88. · DOI
- Wong CT, Tsoi WF, Saha N . Acute phase proteins in male Chinese schizophrenic patients in Singapore. Schizophr Res 1996; 22: 165–171. · DOI
- Chan MK, Guest PC, Levin Y, Umrania Y, Schwarz E, Bahn S et al. Converging evidence of blood-based biomarkers for schizophrenia: An update. Int Rev Neurobiol 2011; 101: 95–144. · DOI
- Inforzato A, Bottazzi B, Garlanda C, Valentino S, Mantovani A . Pentraxins in humoral innate immunity. Adv Exp Med Biol 2012; 946: 1–20. · DOI
- Becker KL, Nylen ES, White JC, Muller B, Snider RH . Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512–1525. · DOI · Paper page
- van Rossum AM, Wulkan RW, Oudesluys-Murphy AM . Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4: 620–630. · DOI · Paper page
- Dalman C, Allebeck P, Gunnell D, Harrison G, Kristensson K, Lewis G et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry 2008; 165: 59–65. · DOI · Paper page
- Koponen H, Rantakallio P, Veijola J, Jones P, Jokelainen J, Isohanni M . Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254: 9–13. · DOI
- Weiser M, Werbeloff N, Levine A, Livni G, Schreiber S, Halperin D et al. CNS infection in childhood does not confer risk for later schizophrenia: a case-control study. Schizophr Res 2010; 124: 231–235. · DOI
- Torrey EF, Yolken RH . Toxoplasma gondii and schizophrenia. Emerg Infect Dis 2003; 9: 1375–1380. · DOI · Paper page
- Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS . Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry 2008; 165: 99–106. · DOI · Paper page
- Pedersen MG, Stevens H, Pedersen CB, Norgaard-Pedersen B, Mortensen PB . Toxoplasma infection and later development of schizophrenia in mothers. Am J Psychiatry 2011; 168: 814–821. · DOI · Paper page
- Leweke FM, Gerth CW, Koethe D, Klosterkotter J, Ruslanova I, Krivogorsky B et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254: 4–8. · DOI · Paper page
- Suzuki Y, Rani S, Liesenfeld O, Kojima T, Lim S, Nguyen TA et al. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect Immun 1997; 65: 2339–2345. · DOI · Paper page
- Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010; 207: 1453–1464. · DOI · Paper page
- Gabay C . Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8 (Suppl 2): S3. · DOI
- Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38: 611–618. · DOI · Paper page
- Teesalu T, Kulla A, Simisker A, Siren V, Lawrence DA, Assera T et al. Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 2004; 92: 358–368. · DOI · Paper page
- de Boer JP, Creasey AA, Chang A, Abbink JJ, Roem D, Eerenberg AJ et al. Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model. Infect Immun 1993; 61: 5035–5043. · DOI
- Blomback B, Hessel B, Hogg D, Therkildsen L . A two-step fibrinogen--fibrin transition in blood coagulation. Nature 1978; 275: 501–505. · DOI · Paper page
- Masopust J, Maly R, Andrys C, Valis M, Bazant J, Hosak L . Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study. BMC psychiatry 2011; 11: 2. · DOI
- Friedman GC, Seeds NW . Tissue plasminogen activator expression in the embryonic nervous system. Brain Res Dev Brain Res 1994; 81: 41–49. · DOI
- Pothakos K, Robinson JK, Gravanis I, Marsteller DA, Dewey SL, Tsirka SE . Decreased serotonin levels associated with behavioral disinhibition in tissue plasminogen activator deficient (tPA-/-) mice. Brain Res 2010; 1326: 135–142. · DOI
- Buckley PF, Pillai A, Howell KR . Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry 2011; 24: 122–127. · DOI · Paper page
- Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H et al. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol 2010; 13: 535–539. · DOI · Paper page
- Siddappa AM, Rao R, Long JD, Widness JA, Georgieff MK . The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations. Neonatology 2007; 92: 73–82. · DOI · Paper page
- Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010; 12: 293–304. · DOI · Paper page
- Insel BJ, Schaefer CA, McKeague IW, Susser ES, Brown AS . Maternal iron deficiency and the risk of schizophrenia in offspring. Arch Gen Psychiatry 2008; 65: 1136–1144. · DOI · Paper page
- Sorensen HJ, Nielsen PR, Pedersen CB, Mortensen PB . Association between prepartum maternal iron deficiency and offspring risk of schizophrenia: population-based cohort study with linkage of Danish national registers. Schizophr Bull 2011; 37: 982–987. · DOI
- Viteri FE . The consequences of iron deficiency and anemia in pregnancy. Adv Exp Med Biol 1994; 352: 127–139. · DOI
- Zornberg GL, Buka SL, Tsuang MT . Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am J Psychiatry 2000; 157: 196–202. · DOI · Paper page
- Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P . Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study. Br J Psychiatry 2001; 179: 403–408. · DOI · Paper page
- Aly H, Hamed Z, Mohsen L, Ramy N, Arnaoot H, Lotfy A . Serum amyloid A protein and hypoxic ischemic encephalopathy in the newborn. J Perinatol 2011; 31: 263–268. · DOI
- Ben Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Usher S, Peretz H et al. Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Thromb Res 2009; 124: 458–462. · DOI
- Lakoski SG, Li L, Langefeld CD, Liu Y, Howard TD, Brosnihan KB et al. The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study. Exp Mol Pathol 2007; 82: 280–283. · DOI
Cited by
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926
Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1332 · Cited by 846
Ligthart, S., Vaez, A., Võsa, U., Stathopoulou, M. G., de Vries, P. S., Prins, B. P., Van der Most, P. J., Tanaka, T., Naderi, E., Rose, L. M., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.09.009 · Cited by 419
Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study
Hartwig, F. P., Borges, M. C., Horta, B. L., Bowden, J., & Davey Smith, G. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3191 · Cited by 302
Metadata
- Authors
- Gardner, R. M., Dalman, C., Wicks, S., Lee, B. K., & Karlsson, H.
- Venue
- Translational Psychiatry
- Published
- 2013-02-19
- Volume
- 3
- Issue
- 2
- Pages
- e228-e228
- ISSN
- 2158-3188
- Cited by
- 46
- References
- 11
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.